Abstract
The depression therapy market is one of the largest in the world. Several antidepressants have achieved blockbuster status. Although the market for antidepressants continues to grow, the rate of growth has slowed, in part because of generics competition. By 2010, the market-leading antidepressants will all face generics competition, at least in the United States. In this report, we examine the current antidepressant market and discuss the effect that increasing generics competition will have.
Table of Contents
Introduction
Depression: Disease Burden, Characteristics, and Prevalence
Current Antidepressant Market
Impact of Generics on Branded Drugs:Case Studies
Key Impending Patent Expiries
Antidepressants in Development
Market Outlook
